NCT06431698 CORRECTION OF EAR DEFORMITIES IN NEWBORNS BY MODELING, COMPARISON OF TWO PROTOCOLS
| NCT ID | NCT06431698 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Caen |
| Condition | Ear Malformation |
| Study Type | INTERVENTIONAL |
| Enrollment | 134 participants |
| Start Date | 2023-07-31 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 134 participants in total. It began in 2023-07-31 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Evaluation of the non-inferiority of the custom-made device developed in the maxillofacial surgery department of Caen University Hospital compared to the device from the EarWell™ group
Eligibility Criteria
Inclusion Criteria: * Newborn, age between 8 days and 1 month * newborn with ear malformation Exclusion Criteria: * Total chondrocutaneous agenesis of the ear * polymalformative syndrome * age greater than 4 weeks * parental refusal
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06431698 clinical trial?
This trial is open to participants of all sexes, up to 1 Month, studying Ear Malformation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06431698 currently recruiting?
Yes, NCT06431698 is actively recruiting participants. Contact the research team at drci-secretariat@chu-caen.fr for enrollment information.
Where is the NCT06431698 trial being conducted?
This trial is being conducted at Caen, France.
Who is sponsoring the NCT06431698 clinical trial?
NCT06431698 is sponsored by University Hospital, Caen. The trial plans to enroll 134 participants.